Blood-Based Biomarkers to Help Screen, Diagnose Alzheimer's

(MedPage Today) -- Qualifying patients for treatment with anti-amyloid monoclonal antibody treatment includes making a specific diagnosis of Alzheimer's disease and demonstrating the presence of amyloid-beta, which now requires a cerebrospinal...

Source: MedPage Today Neurology - February 28, 2024 Category: Neurology Source Type: news